Clinical significance of serum and bone marrow acid phosphatase
- 1 January 1980
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 1 (4), 465-470
- https://doi.org/10.1002/pros.2990010410
Abstract
Currently available immunochemical assays for the determination of serum prostatic acid phosphatase have improved the reliability of this biological marker in carcinoma of the prostate. Although the value of such methods for screening the general population is questionable, a certain percentage of elevated serum levels is observed in patients with localized disease. The significance of such findings is unclear at the present time. Recent evidence suggests that in elevated bone marrow acid phosphatase, using these methods is of predictive value in the future development of metastatic disease.This publication has 33 references indexed in Scilit:
- A solid-phase immunoadsorbent assay for serum prostatic acid phosphataseClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- An Objective Look at Acid Phosphatase Determinations A comparison of biochemical and immunological methodsBritish Journal of Urology, 1979
- Two new, direct, and specific methods of acid phosphatase determination National field trialUrology, 1979
- Counter immunoelectrophoresis for detection of human prostatic acid phosphataseUrology, 1978
- Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancerCancer, 1978
- Human Prostatic Acid Phosphatases: III. Counterimmunoelectrophoresis for Rapid IdentificationArchives of Andrology, 1978
- Human Prostatic Acid Phosphatases: II. A Double-Antibody RadioimmunoassayArchives of Andrology, 1978
- Detection of Prostatic Cancer by Solid-Phase Radioimmunoassay of Serum Prostatic Acid PhosphataseNew England Journal of Medicine, 1977
- Positive random iliac bone biopsy in advanced prostatic cancerUrology, 1973
- Solid-Phase Radioimmunoassay in Antibody-Coated TubesScience, 1967